Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H van der Burg

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Current Opinion in Immunology|September 28, 2000
Design and evaluation of antigen-specific vaccination strategies against cancerR Offringa, S H van der Burg, F Ossendorp, et al.
Annals of the New York Academy of Sciences|July 27, 2000
p53: a potential target antigen for immunotherapy of cancerR Offringa, M P Vierboom, S H van der Burg, et al.
Cancer Treatment Reviews|November 21, 2017
The anti-tumor effect of RANKL inhibition in malignant solid tumors - A systematic reviewA F de Groot, N M Appelman-Dijkstra, S H van der Burg, et al.
Journal of Clinical Pathology|April 17, 2008
FOXP3 immunohistochemistry on formalin-fixed paraffin-embedded tissue: poor correlation between different antibodiesY L Woo, J Sterling, R Crawford, et al.
Journal of Biomedicine & Biotechnology|May 5, 2011
Immunological and clinical effects of vaccines targeting p53-overexpressing malignanciesR Vermeij, N Leffers, S H van der Burg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1996
Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stabilityS H van der Burg, M J Visseren, R M Brandt, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|November 28, 2008
Characterising the local immune responses in cervical intraepithelial neoplasia: a cross-sectional and longitudinal analysisY L Woo, J Sterling, I Damay, et al.
Current Topics in Microbiology and Immunology|June 12, 2003
Interplay between human papillomaviruses and dendritic cellsR Offringa, A de Jong, R E M Toes, et al.
Journal of Translational Medicine|September 17, 2005
Immunologic aspect of ovarian cancer and p53 as tumor antigenH W Nijman, A Lambeck, S H van der Burg, et al.
International Journal of Cancer|February 15, 2001
Identification of three non-VNTR MUC1-derived HLA-A*0201-restricted T-cell epitopes that induce protective anti-tumor immunity in HLA-A2/K(b)-transgenic miceL C Heukamp, S H van der Burg, J W Drijfhout, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Current Opinion in Immunology|September 28, 2000
Design and evaluation of antigen-specific vaccination strategies against cancerR Offringa, S H van der Burg, F Ossendorp, et al.
Annals of the New York Academy of Sciences|July 27, 2000
p53: a potential target antigen for immunotherapy of cancerR Offringa, M P Vierboom, S H van der Burg, et al.
Cancer Treatment Reviews|November 21, 2017
The anti-tumor effect of RANKL inhibition in malignant solid tumors - A systematic reviewA F de Groot, N M Appelman-Dijkstra, S H van der Burg, et al.
Journal of Clinical Pathology|April 17, 2008
FOXP3 immunohistochemistry on formalin-fixed paraffin-embedded tissue: poor correlation between different antibodiesY L Woo, J Sterling, R Crawford, et al.
Journal of Biomedicine & Biotechnology|May 5, 2011
Immunological and clinical effects of vaccines targeting p53-overexpressing malignanciesR Vermeij, N Leffers, S H van der Burg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1996
Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stabilityS H van der Burg, M J Visseren, R M Brandt, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|November 28, 2008
Characterising the local immune responses in cervical intraepithelial neoplasia: a cross-sectional and longitudinal analysisY L Woo, J Sterling, I Damay, et al.
Current Topics in Microbiology and Immunology|June 12, 2003
Interplay between human papillomaviruses and dendritic cellsR Offringa, A de Jong, R E M Toes, et al.
Journal of Translational Medicine|September 17, 2005
Immunologic aspect of ovarian cancer and p53 as tumor antigenH W Nijman, A Lambeck, S H van der Burg, et al.
International Journal of Cancer|February 15, 2001
Identification of three non-VNTR MUC1-derived HLA-A*0201-restricted T-cell epitopes that induce protective anti-tumor immunity in HLA-A2/K(b)-transgenic miceL C Heukamp, S H van der Burg, J W Drijfhout, et al.
Pageof 6